Outcome of laparoscopic Nissen fundoplication in patients with body mass index ≥35

  • M. Anvari
  • F. Bamehriz



To date, few studies have examined the effect of morbid obesity on the outcome of laparoscopic antireflux surgery and results have been conflicting. The aim of this work was to study the outcome of laparoscopic Nissen fundoplication (LNF) in patients with body mass index (BMI) ≥ 35.


We prospectively followed 70 patients (15 men, 55 women) with a proven diagnosis of gastroesophageal reflux disease (GERD) and a mean BMI of 38.4 ± 0.5 (range, 35–51) who underwent LNF. All patients underwent 24-h pH study, esophageal manometry, upper gastrointestinal (GI) endoscopy, and GERD symptom score before and 6 months after LNF. Surgical outcomes were compared to those of 70 sequential nonobese patients (BMI < 30) who also underwent LNF.


LNF was completed laparoscopically in 69 of 70 patients in the morbidly obese (MO) group and in all 70 patients in the normal-weight (NW) group. The mean operative time for the MO group was not significantly longer than that for the NW group (55.9 ± 2.3 min vs 50.0 ± 2.1 min), but the mean length of stay was significantly longer (3.17 ± 0.2 days vs 2.2 ± 0.1 days, p < 0.0001) in the MO group. There was one postoperative complication (a transhiatal herniation of the stomach) in the morbidly obese group. In both patient groups, LNF resulted in a significant increase in lower esophageal sphincter (LES) pressures. This was associated with a significant decrease in percent acid reflux in 24-h testing and a significant improvement in GERD symptom score in both groups, although patients in the MO group had a significantly higher mean reflux symptom score after surgery than did those in the NW group. After a mean follow-up of 41.6 ± 2.9 months, one patient in the MO group required reoperation and one proton pump inhibitor therapy (PRN PPI), as required.


Morbid obesity does not adversely affect the outcome of LNF. The conversion rate is low when performed by an experienced surgeon.


Morbid obesity Antireflux surgery Outcomes 


  1. 1.
    Allen CJ, Parameswaram K, Belda J, Anvari M (2000) Reproducibility, validity, and responsiveness of a disease-specific symptom questionnaire for gastroesophageal reflux disease. Dis Esophagus 13: 265–270CrossRefPubMedGoogle Scholar
  2. 2.
    Anvari M, Allen C (1998) Laparoscopic Nissen fundoplication: two-year comprehensive follow-up of a technique of minimal paraesophageal dissection. Ann Surg 227(1): 25–32CrossRefPubMedGoogle Scholar
  3. 3.
    Campos GM, Peters JH, DeMeester TR, Oberg S, Crookes PF, Tan S, DeMeester SR, Hagen JA, Bremner CG (1999) Multivariate analysis of factors predicting outcome after laparoscopic Nissen fundoplication. J Gastrointest Surg 3: 292–300PubMedGoogle Scholar
  4. 4.
    Fasol R, Schindler M, Schunmaker B (1992) The influence of obesity on perioperative morbidity: retrospective study of 502 aortocoronary bypass operations. Thorac Cardio Surg 40: 126–129Google Scholar
  5. 5.
    Flancbaum L, Choban PS (1998) Surgical implications of obesity. Ann Rev Med 49: 215–234PubMedGoogle Scholar
  6. 6.
    Foley K, Lee RB (1990) Surgical complications of obese patients with endometrial carcinoma. Gynecol Oncol 39(2): 17–4CrossRefPubMedGoogle Scholar
  7. 7.
    Fraser J, Watson DI, O’Boyle CJ, Jameson GG (2001) Obesity and its effect on outcome of laparoscopic Nissen fundoplication. Dis Esophagus 14(1): 50–53CrossRefPubMedGoogle Scholar
  8. 8.
    Hahnloser D, Schumacher M, Calvin R, Cosendey B, Petropoulos P (2002) Risk factors for complications of laparoscopic Nissen fundoplication. Surg Endosc 16: 43–47CrossRefPubMedGoogle Scholar
  9. 9.
    Kulig M, Nocon M, Veith M, Leodolter A, Jaspersen D, Labenz J, Meyer-Sabellek W, Stolte M, Lind T, Malfertheiner P, Willich SN (2004) Risk factors of gastroesophageal reflux disease: methodology and first epidemiological results of the ProGERD study. J Clin Epidemiol 57(6): 580–589CrossRefPubMedGoogle Scholar
  10. 10.
    Leon SM (1999) Obesity. Nutr Hosp 14(2): 92S–104SGoogle Scholar
  11. 11.
    Locke GR 3rd, Talley NJ, Fett SL, Zinsmeister AR, Melton LJ 3rd (1999) Risk factors associated with symptoms of gastroesophageal reflux. Am J Med 106(6): 642–649PubMedGoogle Scholar
  12. 12.
    McNatt SS, Smith CD, Hunter JG, Galloway KG (2000) Morbid obesity does not predict a poor outcome after laparoscopic antireflux surgery (abstr). Gastroenterol 118: A1033Google Scholar
  13. 13.
    Perez AR, Moncure AC, Rattner DW (2001) Obesity adversely affects the outcome of antireflux operations. Surg Endosc 15(9): 986–989CrossRefPubMedGoogle Scholar
  14. 14.
    Postlethwait RW, Johnson WD (1972) Complications following surgery for duodenal ulcer in obese patients. Arch Surg 105: 438–440PubMedGoogle Scholar
  15. 15.
    Riou JA, Cohen JR, Johnson H (1992) Factors influencing wound dehiscence. Am J Surg 163: 324–330CrossRefPubMedGoogle Scholar
  16. 16.
    Winslow ER, Frisella MM, Soper NJ, Klingensmith ME (2003) Obesity does not adversely affect the outcome of laparoscopic antireflux surgery (LARS). Surg Endosc 17: 2003–2011CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, Inc. 2005

Authors and Affiliations

  1. 1.Centre for Minimal Access SurgeryMcMaster UniversityHamiltonCanada

Personalised recommendations